Combination but not single-agent methotrexate chemotherapy for gestational trophoblastic tumors increases the incidence of second tumors

Journal of Clinical Oncology

Volumn 14, Issue 10, 1996, Pages 2769-2773

  Rustin, G J ^a   Newlands, E S ^a   Lutz, J M ^a   Holden, L ^a   Bagshawe, K D ^a   Hiscox, J G ^a   Foskett, M ^a   Fuller, S ^a   Short, D ^a  

^a CHARING CROSS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AZAURIDINE; BLEOMYCIN; CISPLATIN; CYCLOPHOSPHAMIDE; DACTINOMYCIN; DOXORUBICIN; ETOPOSIDE; HYDROXYUREA; MELPHALAN; MERCAPTOPURINE; METHOTREXATE; VINBLASTINE; VINCRISTINE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER INCIDENCE; CANCER RISK; CANCER SURVIVAL; CHORIOCARCINOMA; CLINICAL TRIAL; COLON CANCER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MYELOID LEUKEMIA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RISK ASSESSMENT; SECOND CANCER;

EID: 0029758945     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1996.14.10.2769     Document Type: Article

References (24)

1. Easton DF: The inherited component of cancer. Br Med Bull 3:527-535, 1994
2. Kaldor JM, Day NE, Clarke EA, et al: Leukemia following Hodgkin's disease. N Engl J Med 322:7-13, 1990
3. Greene MH, Harris EL, Gershenson DM, et al: Melphalan may be a more potent leukemogen than cyclophosphamide. Ann Intern" Med 105:360-367, 1986
4. Ratain MJ, Kamminer LS, Bitran JD, et al: Acute non lymphocytic leukemia following etoposide and cisplatin combination chemotherapy for advanced non-small carcinoma of the lung. Blood 70:1412-1417, 1987
5. Pui CH, Ribeiro RC, Hancock ML, et al: Acute myeloid leukemia in children treated with epipodophylotixins for acute lymphoblastic leukemia. N Engl J Med 325:1682-1687, 1991
6. Pedersen-Bjergaard J, Daugaard G, Hansen ST, et al: Increased risk of myelodysplasia and leukaemia after etoposide, cisplatin, and bleomycin for germ cell tumours. Lancet 338:359-363, 1991
7. Boshoff C, Begent RHJ, Oliver RTD, et al: Secondary tumors following etoposide containing therapy for germ cell cancer. Ann Oncol 6:35-40, 1995
8. Whitlock JA, Greger JP, Lukens JN: Epipodophylotoxin-related leukemia. Idenfitication of a new subset of secondary leukemia. Cancer 68:600-604, 1991
9. Hawkins MM, Kinnier Wilson LM, Stovall, MA, et al: Pipodophyllotoxins, alkylating agents, and radiation and risk of secondary leuakaemia after childhood cancer. BMJ 304:951-958, 1992
10. Rustin GJS, Rustin F, Dent J, et al: No increase in second tumors after cytotoxic chemotherapy for gestational trophoblastic tumors. N Engl J Med 308:473-476, 1983
11. Rustin GJS: Trophoblastic diseases, in Shaw R, Soutter P, Staton S (eds): Gynaecology. Edinburgh, United Kingdon, Churchill Livingstone, 1992, pp 557-577
12. Rustin GJS: Late toxicity after therapy of gestational trophoblastic tumours, in Hancock BW, Newlands ES, Bekowitz RS (eds): Gestational Trophoblastic Disease. London, United Kingdom, Chapman Hall (in press)
13. Bagshawe KD: Risk and prognostic factors in trophoblastic neoplasia. Cancer 38:1373-1385, 1976
14. Bagshawe KD, Dent J, Newlands ES, et al: The role of low-dose methotrexate and folinic acid in gestational trophoblastic tumours (GTT). Br J Obstet Gynaecol 96:795-802, 1989
15. Newlands ES, Bagshawe KD, Begent RHJ, et al: Developments in chemotherapy for medium- and high- risk patients with gestational trophoblastic tumours (1979- 1984). Br J Obstet Gynaecol 93:63-69, 1986
16. Newlands ES, Bagshawe KD, Begem RHJ, et al: Results with the EMA/CO (etoposide, methotrexate, actinomycin D, cyclophosphamide, vincristine) regimen in high risk gestational trophoblastic tumours, 1979 to 1989. Br J Obstet Gynaecol 98:550-557, 1991
17. Breslow NE: Elementary methods of cohort analysis. Int J Epidemiol 13:112-115, 1984
18. Coleman M, Douglas A, Hermon C, et al: Cohort study analysis with a FORTRAN computer program. Int J Epidemiol 15:134- 137, 1986
19. Casciato DA, Scott JL: Acute leukaemia following prolonged cytotoxic agent therapy. Medicine 58:32-46, 1979
20. Levine EG, Bloomfield CD: Leukamias and myelodysplastic syndromes secondary to drug, radiation and environmental exposure. Semin Oncol 19:47-84, 1992
21. Swerdlow AJ, Douglas AJ, Hudson VG, et al: Risk of second primary cancers after Hodgkins' s disease by type of treatment: Analysis of 2846 patients in the British National Lymphoma Investigation. BMJ 304:1137-1143, 1992
22. Olson JH, Garwicz S, Hertz H, et al: Second malignant neoplasms after cancer in childhood or adolescence. BMJ 307:1030-1036, 1993
23. Valaussa P, Moliterni A, Terenziani M, et al: Second malignancies following CMF-based adjuvant chemotherapy in resectable breast cancer. Ann Oncol 5:803-808, 1994
24. Arriagada R, Rutqvist LE: Adjuvant chemotherapy in early breast cancer and incidence of new primary malignancies. Lancet 338:535-538, 1991